Skip to main content

Table 1 Demographic information

From: Early onset of treatment effects with oral risperidone

Number of participants:

48 (25 males/23 females)

Age:

36.9 ± 13.4 years (range 18 – 68 years)

PANSS at admission:

110.9 ± 20.4 (range 72 – 158)

CGI at admission:

5.9 ± 0.6 (range 5 – 7)

Duration of treatment:

13.4 ± 9.7 days (range 1 – 31 days)

Maximum dose of risperidone:

6.1 ± 1.4 mg/d (range 4 – 8 mg/d)